Nothing Special   »   [go: up one dir, main page]

Fink, 2019 - Google Patents

Investigating the Role of Myeloid Cells in Giardia Immunity

Fink, 2019

View PDF
Document ID
3755555028037010277
Author
Fink M
Publication year

External Links

Snippet

Human infections with Giardia duodenalis (giardiasis) is regarded as one of the most common human diarrheal disease worldwide with 280 million cases estimated to occur worldwide each year. This parasite lives a biphasic lifestyle either as a dormant cyst or …
Continue reading at repository.library.georgetown.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
US20240307463A1 (en) Composition for inducing proliferation or accumulation of regulatory t cells
Bang et al. Methods of inducing inflammatory bowel disease in mice
Hacini-Rachinel et al. Oral probiotic control skin inflammation by acting on both effector and regulatory T cells
Honda et al. The microbiome in infectious disease and inflammation
Hold et al. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?
Mayne et al. Induced and natural regulatory T cells in the development of inflammatory bowel disease
Wang et al. Helicobacter pylori impairs murine dendritic cell responses to infection
Mosconi et al. Intestinal bacteria induce TSLP to promote mutualistic T-cell responses
PT1530972E (en) Method for screening parasite preparations for efficiency in prevention and control of diseases
Zadeh et al. Induction of intestinal pro-inflammatory immune responses by lipoteichoic acid
Juanola et al. Regulatory T cells restrict permeability to bacterial antigen translocation and preserve short‐chain fatty acids in experimental cirrhosis
Pearson et al. Modulation of the immune system by the gut microbiota in the development of type 1 diabetes
Hamade et al. BATF3 protects against metabolic syndrome and maintains intestinal epithelial homeostasis
Lahiri et al. TLR 9 activation in dendritic cells enhances salmonella killing and antigen presentation via involvement of the reactive oxygen species
US9730988B2 (en) Parasitic biological agents for treatment and prevention of graft versus host disease
Fink Investigating the Role of Myeloid Cells in Giardia Immunity
Donnelly et al. Immunological interaction between Fasciola and its host.
Anwar Impact of helminth infection on antimycobacterial immune responses in UK migrants
Dalton et al. Antigen induced suppression in peripheral blood and lamina propria mononuclear cells in inflammatory bowel disease.
Kittana Deciphering Interactions Between the Gut Microbiota and Host Immune System During Intestinal Inflammation
Linden Time-Dependent and Microbiota-Dependent Effects of Interleukin-22 in a Colitis Mouse Model
Figueiredo-Campos Immune-microbe crosstalk: modulation of adaptive immune system by the microbiota and SARS-CoV2
León Coria et al. Distinct roles of the mucus layer and microbiota in conferring innate host defense and susceptibility to disease
Long The vital role of white adipose tissue in the regulation of intestinal homeostasis and systemic metabolism
Feehley Commensal Bacteria and Their Metabolites Prevent Sensitization to Food Antigens